Prevalence of anxiety and depression in idiopathic pulmonary fibrosis: a systematic review and meta-analysis

医学 焦虑 萧条(经济学) 特发性肺纤维化 荟萃分析 系统回顾 置信区间 梅德林 流行 批判性评价 精神科 出版偏见 子群分析 临床心理学 流行病学 物理疗法 心理健康 患者报告的结果 样本量测定 内科学 报告偏差
作者
Lili Xu,臧丹阳,Ruonan Yan,Zhihui Liang,Shuguang Yang,Ningxia Yu,Xueqing Yu
出处
期刊:BMC Pulmonary Medicine [BioMed Central]
卷期号:26 (1): 357- 被引量:1
标识
DOI:10.1186/s12890-026-04400-1
摘要

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease. Anxiety and depression are prevalent psychiatric comorbidities among IPF patients; however, reported prevalence rates vary substantially, and a consolidated estimate is lacking. This systematic review and meta-analysis aimed to determine the global pooled prevalence of anxiety and depression in IPF patients and to explore potential sources of heterogeneity, thus providing a robust evidence base for clinical management and future research. METHODS: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. A systematic literature search was conducted in PubMed, Web of Science, Cochrane Library, and Embase from database inception to October 23, 2025, to identify studies reporting the prevalence of anxiety or depression in patients with IPF. Two reviewers independently screened the literature, extracted data, and assessed the methodological quality of the included studies using the Joanna Briggs Institute (JBI) critical appraisal checklist. Two separate single-arm meta-analyses were performed, one for studies using International Classification of Diseases, Tenth Revision (ICD-10) criteria and one for those using screening tools (e.g., Hospital Anxiety and Depression Scale, Patient Health Questionnaire-9). Pooled prevalence estimates were calculated using a generalized linear mixed model (GLMM), with corresponding 95% confidence intervals (CIs) and 95% prediction intervals (PIs). Heterogeneity was assessed using Cochran's Q test, the I² statistic, and τ². Sensitivity analyses were conducted using the leave-one-out method and the Freeman-Tukey double arcsine transformation. Subgroup analyses were performed based on study design, geographic region, assessment tool, methodological quality, and sample size. Publication bias was evaluated using Doi plots and the LFK index. RESULTS: A total of 25 studies involving 78,060 IPF patients were included. Among these, 15 studies reported the prevalence of anxiety and 25 reported the prevalence of depression. Studies that did not specify the assessment tool were excluded from the meta-analysis, resulting in the inclusion of 14 studies for the anxiety meta-analysis and 18 studies for the depression meta-analysis. Quantitative analyses were performed separately for the ICD-10 group and the screening tool group. Anxiety in IPF: The pooled prevalence was 14.52% (95% CI: 8.90%-22.79%) in the ICD-10 group (2 studies), with substantial heterogeneity (τ² = 0.1599, I² = 98.9%, P < 0.001); the 95% PI was not calculated due to the small number of studies. In the screening tool group (12 studies), the pooled prevalence was 42.04% (95% CI: 25.28%-60.86%), with a 95% PI of 3.36%-93.80% and substantial heterogeneity (τ² = 1.7068, I² = 88.3%, P < 0.001). Depression in IPF: The pooled prevalence was 6.87% (95% CI: 3.23%-14.04%) in the ICD-10 group (3 studies), with a 95% PI of 0.00%-99.95% and substantial heterogeneity (τ² = 0.4853, I² = 99.8%, P < 0.001). In the screening tool group (15 studies), the pooled prevalence was 38.26% (95% CI: 24.65%-54.01%), with a 95% PI of 3.89%-90.46% and substantial heterogeneity (τ² = 1.4877, I² = 82.3%, P < 0.001). Subgroup analyses based on the screening tool group showed no statistically significant differences in pooled prevalence across study design, assessment tool, geographic region, methodological quality, or sample size (all P > 0.05). Sensitivity analyses confirmed the robustness of the pooled estimates for both anxiety and depression. Publication bias assessment revealed significant bias in the screening tool groups for both outcomes. CONCLUSION: The prevalence of anxiety and depression in IPF patients is substantial and is significantly influenced by the assessment tool used: estimates based on ICD-10 clinical diagnoses are substantially lower than those derived from screening tools. Therefore, future large-scale, high-quality studies employing standardized assessment tools are needed to accurately evaluate the psychiatric comorbidity burden in IPF patients, thereby providing robust evidence for the development of targeted clinical intervention strategies. TRIAL REGISTRATION: PROSPERO; No.: CRD420251174885.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Pursue。完成签到,获得积分10
刚刚
2秒前
TPolymer完成签到,获得积分10
5秒前
脑洞疼的应助被扶竹苏春采纳,获得10
6秒前
化学废材完成签到,获得积分10
7秒前
CodeCraft的应助被hyska采纳,获得10
8秒前
含蓄书桃发布了新的文献求助10
9秒前
9秒前
10秒前
11秒前
健康的魔镜完成签到 ,获得积分10
13秒前
华无剑的应助被DW采纳,获得10
13秒前
14秒前
小乐乐完成签到 ,获得积分10
14秒前
斯文败类的应助被淡淡青枫采纳,获得10
16秒前
17秒前
山海不远发布了新的文献求助10
18秒前
uniphoton完成签到,获得积分10
19秒前
fatal发布了新的文献求助10
21秒前
111发布了新的文献求助10
21秒前
粥粥粥完成签到 ,获得积分10
22秒前
ding的应助被木木采纳,获得10
23秒前
叶上初阳完成签到,获得积分0
23秒前
干咸鱼叔叔完成签到,获得积分10
24秒前
GoGoGo完成签到,获得积分10
25秒前
hitech的应助被fatal采纳,获得10
27秒前
科研通AI6.2的应助被山海不远采纳,获得30
28秒前
含蓄书桃完成签到 ,获得积分10
28秒前
spark发布了新的文献求助10
29秒前
Crazy鑫完成签到,获得积分10
31秒前
32秒前
33秒前
快乐鼠完成签到,获得积分10
35秒前
36秒前
36秒前
WLLLR发布了新的文献求助10
36秒前
桓某人发布了新的文献求助10
37秒前
39秒前
choin6688_完成签到 ,获得积分10
40秒前
lyj发布了新的文献求助10
40秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576127
关于积分的说明 21845709
捐赠科研通 7786389
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482196